Bioceres Crop Solutions Corp BIOX.OQ BIOX.O is expected to show a fall in quarterly revenue when it reports results on February 12 for the period ending December 31 2024
The Rosario Santa Fe-based company is expected to report a 7.6% decrease in revenue to $129.5 million from $140.2 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Bioceres Crop Solutions Corp is for earnings of 9 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Bioceres Crop Solutions Corp is $10.00, above its last closing price of $5.55.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.03 | -0.01 | -0.09 | Missed | -1,100 |
Jun. 30 2024 | 0.24 | 0.24 | -0.03 | Missed | -112.3 |
Mar. 31 2024 | 0.17 | 0.17 | 0.14 | Missed | -17.6 |
Dec. 31 2023 | 0.08 | 0.09 | 0.02 | Missed | -79.3 |
Sep. 30 2023 | 0.06 | 0.06 | -0.07 | Missed | -221.7 |
Jun. 30 2023 | 0.00 | 0.05 | -0.06 | Missed | -230.4 |
Mar. 31 2023 | -0.03 | -0.03 | 0.44 | Beat | 1,792.3 |
Dec. 31 2022 | 0.01 | 0.07 | -0.14 | Missed | -307.4 |
This summary was machine generated February 10 at 13:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。